0001225208-13-006444.txt : 20130304 0001225208-13-006444.hdr.sgml : 20130304 20130304182758 ACCESSION NUMBER: 0001225208-13-006444 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130228 FILED AS OF DATE: 20130304 DATE AS OF CHANGE: 20130304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dawkins Keith D CENTRAL INDEX KEY: 0001492253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 13663129 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 508-650-8000 MAIL ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 4 1 doc4.xml X0306 4 2013-02-28 0000885725 BOSTON SCIENTIFIC CORP BSX 0001492253 Dawkins Keith D ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 EVP, Global Chief Med. Off. Common Stock 2013-02-28 4 M 0 4888.0000 0.0000 A 83396.0000 D Common Stock 2013-02-28 4 F 0 1594.0000 7.3900 D 81802.0000 D Deferred Stock Units 2013-02-28 4 A 0 23680.0000 0.0000 A Common Stock 23680.0000 79458.0000 D Deferred Stock Units 2013-02-28 4 M 0 4888.0000 0.0000 D Common Stock 4888.0000 74570.0000 D Performance Share Units 2013-02-28 4 A 0 31050.0000 0.0000 A 2014-12-31 2014-12-31 Common Stock 31050.0000 31050.0000 D Stock Option (Right to Buy) 7.3900 2013-02-28 4 A 0 61650.0000 0.0000 A 2023-02-28 Common Stock 61650.0000 61650.0000 D Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. Reflects multiple DSU awards with independent vesting schedules. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. On February 27, 2012, the reporting person was awarded a target number of performance share units under the Company's 2012 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2012 adjusted free cash flow measured against its 2012 financial plan over the one-year performance period ending December 31, 2012 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2013, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole on December 31, 2014 upon the completion of the individual service period. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. /s/ Conor Kilroy, Attorney-in-Fact 2013-03-04